These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 757312)

  • 1. New concepts on the interference of alkylating antitumor agents with the regulation of cell division.
    Grunicke H; Gantner G; Holzweber F; Ihlenfeldt M; Puschendorf B
    Adv Enzyme Regul; 1978; 17():291-305. PubMed ID: 757312
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of alkylating antitumor agents on the binding of DNA to protein.
    Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B
    Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
    Ihlenfeldt M; Gantner G; Harrer M; Puschendorf B; Putzer H; Grunicke H
    Cancer Res; 1981 Jan; 41(1):289-93. PubMed ID: 6256062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of thymidine transport at low doses of the alkylating agents triethyleneiminobenzoquinone (Trenimon).
    Grunicke H; Hirsch F; Wolf H; Bauer U; Kiefer G
    Exp Cell Res; 1975 Feb; 90(2):357-64. PubMed ID: 1112277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacodynamic effect of alkylating cytostatics].
    Maass H
    Dtsch Med J; 1968 Mar; 19(5):137-41. PubMed ID: 4887779
    [No Abstract]   [Full Text] [Related]  

  • 6. Depression of the intracellular histone messenger RNA content by the alkylating agent 2,3,5-trisethyleneiminobenzoquinone.
    Raydt G; Holzweber F; Puschendorf B; Grunicke H
    FEBS Lett; 1977 Feb; 74(1):111-4. PubMed ID: 838068
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Effect of triethyleneiminobenzoquinone (trenimon) on thymidine transport in Ehrlich ascites tumor cells.
    Hirsch F; Wolf H; Grunicke H
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1208. PubMed ID: 4477748
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of tumor growth by an alkylation of the plasma membrane.
    Grunicke H; Grünewald K; Helliger W; Scheidl F; Wolff-Schreiner E; Puschendorf B
    Adv Enzyme Regul; 1983; 21():21-30. PubMed ID: 6100583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane as target of alkylating agents.
    Grunicke H; Doppler W; Hofmann J; Lindner H; Maly K; Oberhuber H; Ringsdorf H; Roberts JJ
    Adv Enzyme Regul; 1985; 24():247-61. PubMed ID: 2940819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the mechanism of action of endoxan].
    Grunicke H; Liersch M; Holzer H; Arnold H
    Biochem Pharmacol; 1965 Nov; 14(11):1485-90. PubMed ID: 4286382
    [No Abstract]   [Full Text] [Related]  

  • 11. Different uptake of two alkylating substances by ascites tumor cells.
    Schmidt H; Liss E
    Arzneimittelforschung; 1978; 28(11):2150-2. PubMed ID: 582920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of histone acetylation by alkylating antitumor agents in murine cells.
    Zwierzina H; Loidl A; Fuith LC; Helliger W; Puschendorf B; Grunicke H
    Cancer Res; 1984 Aug; 44(8):3336-9. PubMed ID: 6744267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo studies on the effect of Trenimon (I). Changes of biochemical parameters and inhibition of cell proliferation of Ehrlich ascites tumor cells].
    Liss E; Palme G; Oeff K
    Z Krebsforsch; 1968; 71(1):89-97. PubMed ID: 4299349
    [No Abstract]   [Full Text] [Related]  

  • 14. Depression of histone acetylation by alkylating antitumor agents: significance for antitumor activity and possible biological consequences.
    Grunicke H; Csordas A; Helliger W; Hauptlorenz S; Loidl A; Multhaup I; Zwierzina H; Puschendorf B
    Adv Enzyme Regul; 1984; 22():433-46. PubMed ID: 6475641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hydroxyurea and trisethyleneiminobenzoquinone (Trenimon) on the methylation of DNA in Ehrlich ascites tumor cells.
    Puschendorf B; Grunicke H
    Biochim Biophys Acta; 1972 Jun; 272(1):16-21. PubMed ID: 5043710
    [No Abstract]   [Full Text] [Related]  

  • 16. THE EFFECTS OF THE ALKYLATING CYTOSTATIC AGENT, 2,3,5-TRISETHYLENEIMINO-BENZOQUINONE-1,4(TRENIMON), ON THE PRIMING ABILITY OF DNA FROM MOUSE-ASCITES-TUMOR CELLS IN THE RNA-POLYMERASE-SYSTEM.
    GRUNICKE H; ZIMMERMANN F; HOLZER H
    Biochem Biophys Res Commun; 1965 Feb; 18():319-24. PubMed ID: 14300741
    [No Abstract]   [Full Text] [Related]  

  • 17. [Elimination of I-cells by alkylating cytostatics and their effects on the embryonal development of Hydractinia echniata].
    Müller W
    Exp Cell Res; 1968 Feb; 49(2):448-58. PubMed ID: 4106457
    [No Abstract]   [Full Text] [Related]  

  • 18. [Different influence on the incorporation of radioactive labeled thymidine into the DNA and DNA synthesis using the alkylizing cytostaticum 2,3,5-(trisethyelene-imino)-p-benzoquinone (trenimon)].
    Grunicke H; Hirsch F; Wolf H
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):710-1. PubMed ID: 5069282
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the alkylating agent trisethyleneiminobenzoquinone (trenimon) on the template activity of chromatin and DNA in RNA and DNA polymerase systems.
    Puschendorf B; Wolf H; Grunicke H
    Biochem Pharmacol; 1971 Nov; 20(11):3039-50. PubMed ID: 4943597
    [No Abstract]   [Full Text] [Related]  

  • 20. [On various points of application of trenimon and mitomen in nucleic acid metabolism of tumor cells. (Studies with 3H-thymidine, 3H-cytidine and 32P)].
    Liss E; Palme G; Oeff K
    Nucl Med (Stuttg); 1965; 2():55-61. PubMed ID: 5888980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.